: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Influenza

Free Subscription

Articles published in J Infect Dis
Retrieve available abstracts of 548 articles:
HTML format

Single Articles

September 2021

QI Y, Shaman J, Pei S
Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States.
J Infect Dis. 2021 Sep 22. pii: 6374002. doi: 10.1093.
PubMed Abstract available

XIAO J, de Mesquita JB, Leung NHL, Adenaiye O, et al
Viral RNA and infectious influenza virus on mobile phones of influenza patients in Hong Kong and the United States.
J Infect Dis. 2021 Sep 17. pii: 6371826. doi: 10.1093.
PubMed Abstract available

GORSE GJ, Rattigan SM, Kirpich A, Simberkoff MS, et al
Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel.
J Infect Dis. 2021 Sep 17. pii: 6371937. doi: 10.1093.
PubMed Abstract available

BEVERLAND A, Keogan M, Connell J, De Gascun C, et al
Longitudinal Serological Analysis Following a National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.
J Infect Dis. 2021;224:1100-1101.
PubMed

TONG M, Zheng Q, Chen F, Zhu Y, et al
Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
J Infect Dis. 2021;224:1103-1104.
PubMed

KRISTENSEN MK, Plovsing RR, Berg RMG, Krogh-Madsen R, et al
Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
J Infect Dis. 2021;224:1101-1103.
PubMed

CHOE PG, Kang CK, Kim KH, Yi J, et al
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
J Infect Dis. 2021;224:1097-1099.
PubMed

ERREN TC, Lewis P, Morfeld P
Factoring in Coronavirus Disease 2019 Seasonality: Experiences From Germany.
J Infect Dis. 2021;224:1096.
PubMed

HEATON PM
Herd Immunity: The Journey Is as Important as the Destination.
J Infect Dis. 2021;224:931-933.
PubMed

SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
Feasibility and Performance of Self-Collected Nasal Swabs for Detection of Influenza Virus, Respiratory Syncytial Virus, and Human Metapneumovirus.
J Infect Dis. 2021;224:831-838.
PubMed Abstract available

HILL KJ, Dewar R, Templeton K
A Multiregional Evaluation of Cycle Threshold Values in Severe Acute Respiratory Syndrome Coronavirus 2 VOC-20DEC-01 Variant.
J Infect Dis. 2021;224:927-928.
PubMed

RAN S, Su K, Zhang S, Liu B, et al
The Association Between Coronavirus Disease 2019 Infection and Blood Constituents: A Mendelian Randomization Analysis.
J Infect Dis. 2021;224:922-924.
PubMed

KIM MH, Salloum S, Wang JY, Wong LP, et al
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.
J Infect Dis. 2021;224:777-782.
PubMed Abstract available

NOH JY, Kwak JE, Yang JS, Hwang SY, et al
Longitudinal Assessment of Antisevere Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;224:754-763.
PubMed Abstract available

PATI A, Padhi S, Panda D, Suvankar S, et al
A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population.
J Infect Dis. 2021;224:921-922.
PubMed

August 2021

GIURGEA LT, Cervantes-Medina A, Walters KA, Scherler K, et al
Sex Differences in Influenza: The Challenge Study Experience.
J Infect Dis. 2021 Aug 23. pii: 6356350. doi: 10.1093.
PubMed Abstract available

LINNIK J, Syedbasha M, Kaltenbach HM, Vogt D, et al
Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant (HSCT) patients.
J Infect Dis. 2021 Aug 20. pii: 6355382. doi: 10.1093.
PubMed Abstract available

PEART AKINDELE N, Kouo T, Karaba AH, Gordon O, et al
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
J Infect Dis. 2021;224:606-615.
PubMed Abstract available

BARLEV-GROSS M, Weiss S, Paran N, Yahalom-Ronen Y, et al
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
J Infect Dis. 2021;224:616-619.
PubMed Abstract available

MAZZITELLI I, Bleichmar L, Luduena MG, Pisarevsky A, et al
Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.
J Infect Dis. 2021;224:575-585.
PubMed Abstract available

BANDOPADHYAY P, D'Rozario R, Lahiri A, Sarif J, et al
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
J Infect Dis. 2021;224:565-574.
PubMed Abstract available

PADHI S, Sahu S, Pati A, Mohanty AK, et al
Minor Allele of Intercellular Adhesion Molecule-1 Polymorphism (rs5498 1462A>G) Is Associated With SARS-CoV-2 Infection and Related Mortality.
J Infect Dis. 2021;224:734-735.
PubMed

SOUTHWICK FS
Improving the Definition of Coronavirus Disease 2019-Related Deaths.
J Infect Dis. 2021;224:375-376.
PubMed

AVIV R, Weber A, Anzum T, Federbush M, et al
Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.
J Infect Dis. 2021;224:557-559.
PubMed

ALLAN-BLITZ LT, Klausner JD
Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
J Infect Dis. 2021;224:556-557.
PubMed

HALL JA, Harris RJ, Emmett HE, Lowe B, et al
On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2.
J Infect Dis. 2021;224:389-394.
PubMed Abstract available

MEISTER TL, Fortmann J, Todt D, Heinen N, et al
Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351.
J Infect Dis. 2021;224:420-424.
PubMed Abstract available

ALKHARAAN H, Bayati S, Hellstrom C, Aleman S, et al
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
J Infect Dis. 2021;224:407-414.
PubMed Abstract available

BOUMAZA A, Gay L, Mezouar S, Bestion E, et al
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
J Infect Dis. 2021;224:395-406.
PubMed Abstract available

July 2021

EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
PubMed Abstract available

PARROTT JC, Maleki AN, Vassor VE, Osahan S, et al
Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
J Infect Dis. 2021;224:188-195.
PubMed Abstract available

CASADO JL, Vizcarra P, Velasco H, Hammerle J, et al
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;224:241-245.
PubMed Abstract available

PANDA AK, Pati A, Padhi S, Sahoo AK, et al
Association of Granulin rs5848 (C>T) Polymorphism With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality Rate.
J Infect Dis. 2021;224:366-367.
PubMed

BERNAL E, Gimeno L, Alcaraz MJ, Quadeer AA, et al
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;224:229-240.
PubMed Abstract available

JALKANEN P, Pasternack A, Maljanen S, Melen K, et al
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
J Infect Dis. 2021;224:218-228.
PubMed Abstract available

VILLARINO E, Deng X, Kemper CA, Jorden MA, et al
Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California.
J Infect Dis. 2021;224:207-217.
PubMed Abstract available

PATHELA P, Crawley A, Weiss D, Maldin B, et al
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
J Infect Dis. 2021;224:196-206.
PubMed Abstract available

HALL MD, Anderson JM, Anderson A, Baker D, et al
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
J Infect Dis. 2021;224.
PubMed Abstract available

SYED F, Li W, Relich RF, Russell PM, et al
Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.
J Infect Dis. 2021;224:60-69.
PubMed Abstract available

DA SILVA ANTUNES R, Pallikkuth S, Williams E, Dawen Yu E, et al
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
J Infect Dis. 2021;224:70-80.
PubMed Abstract available

PETRIE JG, Bazzi LA, McDermott AB, Follmann D, et al
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
J Infect Dis. 2021;224:49-59.
PubMed Abstract available

KANG CK, Kim M, Lee S, Kim G, et al
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;224:39-48.
PubMed Abstract available

DEE K, Goldfarb DM, Haney J, Amat JAR, et al
Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
J Infect Dis. 2021;224:31-38.
PubMed Abstract available

KRAAY ANM, Han P, Kambhampati AK, Wikswo ME, et al
Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States.
J Infect Dis. 2021;224:9-13.
PubMed Abstract available

DILLNER J, Elfstrom KM, Blomqvist J, Engstrand L, et al
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
J Infect Dis. 2021;224:14-20.
PubMed Abstract available

GIACOMELLI CAO R, Christian L, Xu Z, Jaramillo L, et al
Early changes in interferon gene expression and antibody responses following influenza vaccination in pregnant women.
J Infect Dis. 2021 Jul 1. pii: 6312681. doi: 10.1093.
PubMed Abstract available

June 2021

BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
PubMed Abstract available

HAAGMANS BL, Noack D, Okba NMA, Li W, et al
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
J Infect Dis. 2021;223:2020-2028.
PubMed Abstract available

HAWLEY HB, Chang JC
Complement-Induced Endotheliopathy-Associated Vascular Microthrombosis in Coronavirus Disease 2019.
J Infect Dis. 2021;223:2198-2199.
PubMed

RAMOS DA SILVA S, Ju E, Meng W, Paniz Mondolfi AE, et al
Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
J Infect Dis. 2021;223:1842-1854.
PubMed Abstract available

ROSENBERG ES, Tesoriero JM
A Tale of Many New York Cities.
J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
PubMed

May 2021

SCHNIERLE BS
Reply to Ringlander et al.
J Infect Dis. 2021;223:1833.
PubMed

RINGLANDER J, Martner A, Nilsson S, Westin J, et al
Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses.
J Infect Dis. 2021;223:1831-1832.
PubMed

LU L, Koh CT, Lim YH, Sng A, et al
Role of Asymptomatic Children in Community Severe Acute Respiratory Syndrome Coronavirus 2 Transmission.
J Infect Dis. 2021;223:1834-1836.
PubMed

HAYMOND A, Damluji AA, Narayanan A, Mueller C, et al
Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
J Infect Dis. 2021;223:1677-1680.
PubMed Abstract available

ACOSTA-AMPUDIA Y, Rojas M, Monsalve DM, Rodriguez Y, et al
Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.
J Infect Dis. 2021;223:1833-1834.
PubMed

PEREIRA C, Harris BHL, Di Giovannantonio M, Rosadas C, et al
The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
J Infect Dis. 2021;223:1671-1676.
PubMed Abstract available

LEMIEUX JE, Li JZ
Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.
J Infect Dis. 2021;223:1663-1665.
PubMed

KIDD M, Richter A, Best A, Cumley N, et al
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.
J Infect Dis. 2021;223:1666-1670.
PubMed Abstract available

DAWOOD FS, Varner M, Munoz F, Stockwell MS, et al
Respiratory Viral Infections and Infection Prevention Practices among Women with Acute Respiratory Illness during Delivery Hospitalizations during the 2019-2020 Influenza Season.
J Infect Dis. 2021 May 25. pii: 6284115. doi: 10.1093.
PubMed Abstract available

XIE C, Su W, Sia SF, Choy KT, et al
A(H1N1)pdm09 influenza viruses replicating in ferret upper or lower respiratory tract differed in onward transmission potential by air.
J Infect Dis. 2021 May 24. pii: 6283765. doi: 10.1093.
PubMed Abstract available

FELDSTEIN LR, Ferdinands JM, Self WH, Randolph AG, et al
Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.
J Infect Dis. 2021 May 20. pii: 6278475. doi: 10.1093.
PubMed Abstract available

SYNOLAKI E, Papadopoulos V, Divolis G, Tsahouridou O, et al
The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality.
J Infect Dis. 2021;223:1544-1554.
PubMed Abstract available

AVADHANULA V, Nicholson EG, Ferlic-Stark L, Piedra FA, et al
Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader.
J Infect Dis. 2021;223:1528-1537.
PubMed Abstract available

RAMAN RS, Bhagwan Barge V, Anil Kumar D, Dandu H, et al
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
J Infect Dis. 2021;223:1538-1543.
PubMed Abstract available

TARHINI H, Recoing A, Bridier-Nahmias A, Rahi M, et al
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
J Infect Dis. 2021;223:1522-1527.
PubMed Abstract available

RICHARDS KA, Glover M, Crawford JC, Thomas PG, et al
Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.
J Infect Dis. 2021;223:1555-1563.
PubMed Abstract available

CHEN J, Vitetta L
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.
J Infect Dis. 2021;223:1659-1660.
PubMed

OUWENDIJK WJD, Raadsen MP, van Kampen JJA, Verdijk RM, et al
High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
J Infect Dis. 2021;223:1512-1521.
PubMed Abstract available

TELUGUAKULA N
Neutrophils Set Extracellular Traps to Injure Lungs in Coronavirus Disease 2019.
J Infect Dis. 2021;223:1503-1505.
PubMed

BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
PubMed Abstract available

CHA S, Henry A, Montgomery MP, Laws RL, et al
Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
PubMed Abstract available

April 2021

BAO L, Song Z, Xue J, Gao H, et al
Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
J Infect Dis. 2021;223:1313-1321.
PubMed Abstract available

DAVIS MF, Innes GK
The Cat's in the Bag: Despite Limited Cat-to-Cat Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, One Health Surveillance Efforts Are Needed.
J Infect Dis. 2021;223:1309-1312.
PubMed

LUZZATTO-FEGIZ P, Temprano-Coleto F, Peaudecerf FJ, Landel JR, et al
UVB Radiation Alone May Not Explain Sunlight Inactivation of SARS-CoV-2.
J Infect Dis. 2021;223:1500-1502.
PubMed

JANSSEN NAF, Grondman I, de Nooijer AH, Boahen CK, et al
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
J Infect Dis. 2021;223:1322-1333.
PubMed Abstract available

BAUER W, Ulke J, Galtung N, Strasser-Marsik LC, et al
Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department.
J Infect Dis. 2021;223:1497-1499.
PubMed

THIEDE JM, Gress AR, Libby SD, Ronayne CE, et al
Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial.
J Infect Dis. 2021;223:1339-1344.
PubMed Abstract available

BOLOTIN S, Tran V, Osman S, Brown KA, et al
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
J Infect Dis. 2021;223:1334-1338.
PubMed Abstract available

MCCARTNEY MM, Linderholm AL, Yamaguchi MS, Falcon AK, et al
Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions.
J Infect Dis. 2021 Apr 15. pii: 6226913. doi: 10.1093.
PubMed Abstract available

EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
PubMed Abstract available

SATO M, Takashita E, Katayose M, Nemoto K, et al
Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
PubMed Abstract available

ABBOUD H
Encephalitis in the Setting of COVID-19 Infection.
J Infect Dis. 2021;223:1303.
PubMed

TJAN LH, Furukawa K, Nagano T, Kiriu T, et al
Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
J Infect Dis. 2021;223:1145-1149.
PubMed Abstract available

RATHE JA, Hemann EA, Eggenberger J, Li Z, et al
SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
J Infect Dis. 2021;223:1120-1131.
PubMed Abstract available

March 2021

LAMARCA JH, de Carvalho FG, Machado FC, Lacerda-Santos R, et al
Severe Acute Respiratory Syndrome Coronavirus 2: A Protocol for Disinfection of Toothbrushes.
J Infect Dis. 2021;223:1113-1114.
PubMed

KLINGLER J, Weiss S, Itri V, Liu X, et al
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2021;223:957-970.
PubMed Abstract available

HUGHES EC, Amat JAR, Haney J, Parr YA, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
J Infect Dis. 2021;223:971-980.
PubMed Abstract available

STRICH JR, Ramos-Benitez MJ, Randazzo D, Stein SR, et al
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
J Infect Dis. 2021;223:981-984.
PubMed Abstract available

IZURIETA HS, Graham DJ, Jiao Y, Hu M, et al
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
J Infect Dis. 2021;223:945-956.
PubMed Abstract available

PETITO E, Falcinelli E, Paliani U, Cesari E, et al
Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
J Infect Dis. 2021;223:933-944.
PubMed Abstract available

LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
PubMed Abstract available

MCBRIDE DS, Perofsky AC, Nolting JM, Nelson MI, et al
Tracing the source of influenza A virus zoonoses in interconnected circuits of swine exhibitions.
J Infect Dis. 2021 Mar 4. pii: 6158869. doi: 10.1093.
PubMed Abstract available

BHATNAGAR J, Gary J, Reagan-Steiner S, Estetter LB, et al
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
J Infect Dis. 2021;223:752-764.
PubMed Abstract available

GIRARDIN RC, Dupuis AP, Payne AF, Sullivan TJ, et al
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
J Infect Dis. 2021;223:743-751.
PubMed Abstract available

BLOCH EM, Crowe EP, Tobian AAR
Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.
J Infect Dis. 2021;223:740-742.
PubMed

ZHENG J, Wang Y, Li K, Meyerholz DK, et al
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.
J Infect Dis. 2021;223:785-795.
PubMed Abstract available

KLUMPP-THOMAS C, Kalish H, Hicks J, Mehalko J, et al
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.
J Infect Dis. 2021;223:802-804.
PubMed Abstract available

BOWMAN ER, Cameron CMA, Avery A, Gabriel J, et al
Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019.
J Infect Dis. 2021;223:805-810.
PubMed Abstract available

RIEDER M, Wirth L, Pollmeier L, Jeserich M, et al
Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.
J Infect Dis. 2021;223:775-784.
PubMed Abstract available

JAHRSDORFER B, Kroschel J, Ludwig C, Corman VM, et al
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
J Infect Dis. 2021;223:796-801.
PubMed Abstract available

CHATZIDIMITRIOU M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, et al
Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019.
J Infect Dis. 2021;223:924-926.
PubMed

CHORENO-PARRA JA, Jimenez-Alvarez LA, Ramirez-Martinez G, Cruz-Lagunas A, et al
Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19.
J Infect Dis. 2021 Mar 1. pii: 6154795. doi: 10.1093.
PubMed Abstract available

February 2021

BULFONE TC, Malekinejad M, Rutherford GW, Razani N, et al
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
J Infect Dis. 2021;223:550-561.
PubMed Abstract available

LERSY F, Benotmane I, Helms J, Collange O, et al
Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
J Infect Dis. 2021;223:600-609.
PubMed Abstract available

TRIEU MC, Bansal A, Madsen A, Zhou F, et al
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
J Infect Dis. 2021;223:589-599.
PubMed Abstract available

SINHA P, Jafarzadeh SR, Assoumou SA, Bielick CG, et al
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
J Infect Dis. 2021;223:581-588.
PubMed Abstract available

BEDIN AS, Makinson A, Picot MC, Mennechet F, et al
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
J Infect Dis. 2021;223:562-567.
PubMed Abstract available

LI A, Ling Y, Song Z, Cheng X, et al
Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:568-580.
PubMed Abstract available

DAI M, Li H, Yan N, Huang J, et al
Long-term Survival of SARS-CoV-2 on Salmon as a Source for International Transmission.
J Infect Dis. 2021;223:537-539.
PubMed

MOHKHEDKAR M, Venigalla SSK, Janakiraman V
Autoantigens That May Explain Postinfection Autoimmune Manifestations in Patients With Coronavirus Disease 2019 Displaying Neurological Conditions.
J Infect Dis. 2021;223:536-537.
PubMed

MUECKSCH F, Wise H, Batchelor B, Squires M, et al
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.
J Infect Dis. 2021;223:389-398.
PubMed Abstract available

GOLDSTEIN E, Lipsitch M, Cevik M
On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.
J Infect Dis. 2021;223:362-369.
PubMed Abstract available

LIM JT, Chew LZX, Choo ELW, Dickens BSL, et al
Increased Dengue Transmissions in Singapore Attributable to SARS-CoV-2 Social Distancing Measures.
J Infect Dis. 2021;223:399-402.
PubMed Abstract available

MAROSSY A, Rakowicz S, Bhan A, Noon S, et al
A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
J Infect Dis. 2021;223:381-388.
PubMed Abstract available

GALANTI M, Shaman J
Direct Observation of Repeated Infections With Endemic Coronaviruses.
J Infect Dis. 2021;223:409-415.
PubMed Abstract available

BEHR MA, Divangahi M, Schurr E
Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
J Infect Dis. 2021;223:189-191.
PubMed Abstract available

HARRIS BHL, Zuhair M, Di Giovannantonio M, Rosadas C, et al
Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
J Infect Dis. 2021;223:192-196.
PubMed Abstract available

BRANDSMA E, Verhagen HJMP, van de Laar TJW, Claas ECJ, et al
Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
J Infect Dis. 2021;223:206-213.
PubMed Abstract available

CRAWFORD KHD, Dingens AS, Eguia R, Wolf CR, et al
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:197-205.
PubMed Abstract available

DE NOOIJER AH, Grondman I, Janssen NAF, Netea MG, et al
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
J Infect Dis. 2021;223:214-224.
PubMed Abstract available

MANSBACH JM, Geller RJ, Hasegawa K, Piedra PA, et al
Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing.
J Infect Dis. 2021;223:268-277.
PubMed Abstract available

January 2021

JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
PubMed Abstract available

EATON EF, Clement ME
Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
PubMed

SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
PubMed Abstract available

BUI CHT, Yeung HW, Ho JCW, Leung CYH, et al
Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants.
J Infect Dis. 2021 Jan 4. pii: 6062634. doi: 10.1093.
PubMed Abstract available

LI L, Huang M, Shen J, Wang Y, et al
Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
J Infect Dis. 2021;223:178-179.
PubMed

MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
J Infect Dis. 2021;223:62-71.
PubMed Abstract available

HENSS L, Scholz T, von Rhein C, Wieters I, et al
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2021;223:56-61.
PubMed Abstract available

LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
J Infect Dis. 2021;223:47-55.
PubMed Abstract available

SUN H, Jain A, Leone MJ, Alabsi HS, et al
CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
J Infect Dis. 2021;223:38-46.
PubMed Abstract available

BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
J Infect Dis. 2021;223:23-27.
PubMed Abstract available

ZHU J, Wu C, Wu L
Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
J Infect Dis. 2021;223:19-22.
PubMed Abstract available

YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
J Infect Dis. 2021;223:15-18.
PubMed Abstract available

PATI A, Padhi S, Suvankar S, Panda AK, et al
Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
J Infect Dis. 2021;223:175-178.
PubMed

KIDDE J, Sahebkar A
From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
J Infect Dis. 2021;223:174-175.
PubMed

HICKS SM, Pohl K, Neeman T, McNamara HA, et al
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
J Infect Dis. 2021;223:10-14.
PubMed Abstract available

PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
J Infect Dis. 2021;223:28-37.
PubMed Abstract available

PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
PubMed Abstract available

TONG M, Zheng Q, Zhu Y
Reply to Li et al.
J Infect Dis. 2021;223:179-180.
PubMed

LEMPAINEN J, Korhonen LS, Kantojarvi K, Heinonen S, et al
Associations Between IFI44L Gene Variants and Rates of Respiratory Tract Infections During Early Childhood.
J Infect Dis. 2021;223:157-165.
PubMed Abstract available

MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
PubMed Abstract available

December 2020

TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
PubMed Abstract available

KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
PubMed Abstract available

KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
Influenza Vaccine Failure Associated with Age and Immunosuppression.
J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
PubMed Abstract available

FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
PubMed Abstract available

November 2020

CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
PubMed Abstract available

TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
J Infect Dis. 2020;222:1951-1954.
PubMed Abstract available

SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
J Infect Dis. 2020;222:1960-1964.
PubMed Abstract available

VITTE J, Diallo AB, Boumaza A, Lopez A, et al
A Granulocytic Signature Identifies COVID-19 and Its Severity.
J Infect Dis. 2020;222:1985-1996.
PubMed Abstract available

BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
J Infect Dis. 2020;222:1974-1984.
PubMed Abstract available

NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
J Infect Dis. 2020;222:1955-1959.
PubMed Abstract available

GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
J Infect Dis. 2020;222:1965-1973.
PubMed Abstract available

SCHIEFFELIN JS
Infectious Disease Outbreaks: The Need For an All-in Approach.
J Infect Dis. 2020;222:1941-1942.
PubMed

FALASCA L, Nardacci R, Colombo D, Lalle E, et al
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
J Infect Dis. 2020;222:1807-1815.
PubMed Abstract available

BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
J Infect Dis. 2020;222:1798-1806.
PubMed Abstract available

STERLING RK, Oakes T, Gal TS, Stevens MP, et al
The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
J Infect Dis. 2020;222:1794-1797.
PubMed Abstract available

GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
J Infect Dis. 2020;222:1789-1793.
PubMed Abstract available

ZOU Y, Wang BR, Sun L, Xu S, et al
The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
J Infect Dis. 2020;222:1784-1788.
PubMed Abstract available

FJELLTVEIT EB, Cox RJ, Ostensjo J, Blomberg B, et al
Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.
J Infect Dis. 2020 Nov 5. pii: 5957176. doi: 10.1093.
PubMed Abstract available

MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
PubMed Abstract available

SALMON DA, Dudley MZ, Carleton BC
Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
PubMed

PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
PubMed Abstract available

October 2020

WANG W, Chen X, Wang Y, Lai S, et al
Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.
J Infect Dis. 2020 Oct 29. pii: 5943032. doi: 10.1093.
PubMed Abstract available

HINOJOSA M, Shepard SS, Chung JR, King JP, et al
Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
PubMed Abstract available

MANCINI F, Barbanti F, Scaturro M, Fontana S, et al
Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting.
J Infect Dis. 2020 Oct 20. pii: 5932324. doi: 10.1093.
PubMed Abstract available

SHANNON I, White CL, Yang H, Nayak JL, et al
Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
PubMed Abstract available

WEISS S, Klingler J, Hioe C, Amanat F, et al
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1629-1634.
PubMed Abstract available

SAUCEDA JA, Neilands TB, Lightfoot M, Saberi P, et al
Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1607-1611.
PubMed Abstract available

SUGANO N, Ando W, Fukushima W
Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
J Infect Dis. 2020;222:1635-1640.
PubMed Abstract available

BRADFUTE SB, Hurwitz I, Yingling AV, Ye C, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:1620-1628.
PubMed Abstract available

KOO BS, Oh H, Kim G, Hwang EH, et al
Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.
J Infect Dis. 2020;222:1596-1600.
PubMed Abstract available

LURIE MN, Silva J, Yorlets RR, Tao J, et al
Coronavirus Disease 2019 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions.
J Infect Dis. 2020;222:1601-1606.
PubMed Abstract available

LAI CKC, Chen Z, Lui G, Ling L, et al
Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
J Infect Dis. 2020;222:1612-1619.
PubMed Abstract available

SHI T, Arnott A, Semogas I, Falsey AR, et al
The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

MILLER M
Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
J Infect Dis. 2020;222.
PubMed

REEVES RM, van Wijhe M, Tong S, Lehtonen T, et al
Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
J Infect Dis. 2020;222.
PubMed Abstract available

LI Y, Campbell H, Nair H
Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design.
J Infect Dis. 2020;222.
PubMed Abstract available

WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
J Infect Dis. 2020;222.
PubMed Abstract available

JEFFERIES K, Drysdale SB, Robinson H, Clutterbuck EA, et al
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
J Infect Dis. 2020;222.
PubMed Abstract available

CHUNG A, Reeves RM, Nair H, Campbell H, et al
Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
J Infect Dis. 2020;222.
PubMed Abstract available

ONER D, Drysdale SB, McPherson C, Lin GL, et al
Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
J Infect Dis. 2020;222.
PubMed Abstract available

LIN GL, Golubchik T, Drysdale S, O'Connor D, et al
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
J Infect Dis. 2020;222.
PubMed Abstract available

ZUURBIER RP, Bont LJ, Langedijk AC, Hamer M, et al
Low Sensitivity of BinaxNOW RSV in Infants.
J Infect Dis. 2020;222.
PubMed Abstract available

WISEMAN DJ, Thwaites RS, Drysdale SB, Janet S, et al
Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
J Infect Dis. 2020;222.
PubMed Abstract available

ZHANG S, Akmar LZ, Bailey F, Rath BA, et al
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

CHAW PS, Hua L, Cunningham S, Campbell H, et al
Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

CHAW PS, Wong SWL, Cunningham S, Campbell H, et al
Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

SHI T, Ooi Y, Zaw EM, Utjesanovic N, et al
Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood.
J Infect Dis. 2020;222.
PubMed Abstract available

SHI T, Denouel A, Tietjen AK, Campbell I, et al
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
J Infect Dis. 2020;222.
PubMed Abstract available

LI D, Wolk DM, Cantor MN
Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records.
J Infect Dis. 2020 Oct 3. pii: 5917765. doi: 10.1093.
PubMed Abstract available

RABELO-DA-PONTE FD, Silvello D, Scherer JN, Ayala AR, et al
Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
J Infect Dis. 2020;222:1575-1578.
PubMed

DEN HARTOG G, Schepp RM, Kuijer M, GeurtsvanKessel C, et al
SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
J Infect Dis. 2020;222:1452-1461.
PubMed Abstract available

SCHIAFFINO MT, Di Natale M, Garcia-Martinez E, Navarro J, et al
Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
J Infect Dis. 2020;222:1439-1443.
PubMed Abstract available

WANG W, Liu X, Wu S, Chen S, et al
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
J Infect Dis. 2020;222:1444-1451.
PubMed Abstract available

ZENG QL, Yu ZJ, Ji F
Reply to Rabelo-da-Ponte et al.
J Infect Dis. 2020;222:1578.
PubMed

HAYDEN FG, Whitley RJ
Respiratory Syncytial Virus Antivirals: Problems and Progress.
J Infect Dis. 2020;222:1417-1421.
PubMed

STRAY K, Perron M, Porter DP, Anderson F, et al
Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
J Infect Dis. 2020;222:1468-1477.
PubMed Abstract available

September 2020

PENKERT RR, Smith AP, Hrincius ER, McCullers JA, et al
Vitamin A deficiency dysregulates immune responses toward influenza virus and increases mortality after bacterial coinfections.
J Infect Dis. 2020 Sep 22. pii: 5909831. doi: 10.1093.
PubMed Abstract available

ZHAO T
Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
J Infect Dis. 2020;222:1413.
PubMed

LI JZ, Yu XG
Overcoming Challenges in Coronavirus Disease 19 Translational Research.
J Infect Dis. 2020;222:1254-1255.
PubMed

LIU X, Tang J, Xie R, Li W, et al
Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
J Infect Dis. 2020;222:1293-1297.
PubMed Abstract available

BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
J Infect Dis. 2020;222:1280-1288.
PubMed Abstract available

LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
J Infect Dis. 2020;222:1270-1279.
PubMed Abstract available

MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2020;222:1289-1292.
PubMed Abstract available

RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
J Infect Dis. 2020;222:1265-1269.
PubMed Abstract available

LAM KW, Chow KW, Vo J, Hou W, et al
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
J Infect Dis. 2020;222:1256-1264.
PubMed Abstract available

FALSEY AR, Walsh EE
Respiratory Syncytial Virus: An Old Foe in a New Era.
J Infect Dis. 2020;222:1245-1246.
PubMed

TSENG HF, Sy LS, Ackerson B, Solano Z, et al
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;222:1298-1310.
PubMed Abstract available

FILL MA
Multistate Outbreak of Seoul Virus: Implications for the One Health Movement and Pandemic Preparedness.
J Infect Dis. 2020;222:1247-1249.
PubMed

LEI H, Xu M, Wang X, Xie Y, et al
Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
PubMed Abstract available

HADLER JL
Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
PubMed

ZIMMERMAN RK, South-Paul JE, Poland GA
Rationing of civilian COVID-19 vaccines while supplies are limited.
J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
PubMed

NALIN D
Immunosenescence and SARS-CoV-2 Vaccine Development.
J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
PubMed

LI Y, Wang X, Nair H
Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
J Infect Dis. 2020;222:1090-1097.
PubMed Abstract available

SHOOK-SA BE, Boyce RM, Aiello AE
Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
J Infect Dis. 2020;222:1086-1089.
PubMed Abstract available

HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
J Infect Dis. 2020;222:1103-1107.
PubMed Abstract available

YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
J Infect Dis. 2020;222:1098-1102.
PubMed Abstract available

SIEDNER MJ, Gandhi RT, Kim AY
Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.
J Infect Dis. 2020;222:1084-1085.
PubMed

OFMAN G, Pradarelli B, Caballero MT, Bianchi A, et al
Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
J Infect Dis. 2020;222:1129-1137.
PubMed Abstract available

August 2020

TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
Are SARS-CoV-2 seroprevalence estimates biased?
J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
PubMed

SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
PubMed Abstract available

HASFORD J
Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
PubMed

VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
PubMed Abstract available

SHI D, Wu W, Wang Q, Xu K, et al
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
J Infect Dis. 2020;222:910-918.
PubMed Abstract available

KULLAR R, Marcelin JR, Swartz TH, Piggott DA, et al
Racial Disparity of Coronavirus Disease 2019 in African American Communities.
J Infect Dis. 2020;222:890-893.
PubMed Abstract available

PILCHER CD, Westreich D, Hudgens MG
Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence.
J Infect Dis. 2020;222:903-909.
PubMed Abstract available

TONG M, Jiang Y, Xia D, Xiong Y, et al
Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
J Infect Dis. 2020;222:894-898.
PubMed Abstract available

HALSTEAD SB, Katzelnick L
COVID 19 Vaccines: Should we fear ADE?
J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
PubMed Abstract available

PANG Y, Wang Q, Lv M, Yu M, et al
Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
PubMed Abstract available

GILCA R, Carazo S, Amini R, Charest H, et al
Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.
J Infect Dis. 2020 Aug 6. pii: 5882014. doi: 10.1093.
PubMed Abstract available

BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
Health-care seeking behavior for respiratory illness among Flu Near You participants in the United States during the 2015-16 through 2018-19 influenza season.
J Infect Dis. 2020 Aug 6. pii: 5881614. doi: 10.1093.
PubMed Abstract available

KANZAWA M, Spindler H, Anglemyer A, Rutherford GW, et al
Will Coronavirus Disease 2019 Become Seasonal?
J Infect Dis. 2020;222:719-721.
PubMed Abstract available

VOO TC, Clapham H, Tam CC
Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
J Infect Dis. 2020;222:715-718.
PubMed Abstract available

CHI Y, Ge Y, Wu B, Zhang W, et al
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
J Infect Dis. 2020;222:746-754.
PubMed Abstract available

IBANEZ-SAMANIEGO L, Bighelli F, Uson C, Caravaca C, et al
Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
J Infect Dis. 2020;222:726-733.
PubMed Abstract available

YANG D, Chu H, Hou Y, Chai Y, et al
Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
J Infect Dis. 2020;222:734-745.
PubMed Abstract available

CLEMENTI N, Ferrarese R, Criscuolo E, Diotti RA, et al
Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
J Infect Dis. 2020;222:722-725.
PubMed Abstract available

WONG MCS, Huang J, Teoh JYC, Wong SH, et al
Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
J Infect Dis. 2020;222:880-881.
PubMed

DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
Corrigendum to: Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.
J Infect Dis. 2020 Aug 1. pii: 5879633. doi: 10.1093.
PubMed

July 2020

MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
PubMed Abstract available

PANDA AK, Tripathy R, Das BK
Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
J Infect Dis. 2020 Jul 29. pii: 5878042. doi: 10.1093.
PubMed

LI P, Liu J, Ma Z, Bramer WM, et al
Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context.
J Infect Dis. 2020;222:695-696.
PubMed

PINTO BGG, Oliveira AER, Singh Y, Jimenez L, et al
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
J Infect Dis. 2020;222:556-563.
PubMed Abstract available

SCHUIT M, Ratnesar-Shumate S, Yolitz J, Williams G, et al
Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.
J Infect Dis. 2020;222:564-571.
PubMed Abstract available

BAO L, Gao H, Deng W, Lv Q, et al
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
J Infect Dis. 2020;222:551-555.
PubMed Abstract available

NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
Reply to Li et al.
J Infect Dis. 2020;222:696-698.
PubMed

TRICOCHE AD, Wagner AL, Balmaseda A, Sanchez N, et al
Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.
J Infect Dis. 2020 Jul 16. pii: 5872037. doi: 10.1093.
PubMed Abstract available

SCHLOM J, Donahue RN
Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
PubMed

DAWSON L, Earl J, Livezey J
Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
J Infect Dis. 2020;222:514-516.
PubMed

ZENG QL, Ji F, Zhang JY
Response to Malkovsky.
J Infect Dis. 2020;222:510-511.
PubMed

HAO S, Lian J, Lu Y, Jia H, et al
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
J Infect Dis. 2020;222:367-371.
PubMed Abstract available

TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
J Infect Dis. 2020;222:362-366.
PubMed Abstract available

LARGENT EA, Lynch HF
Paying Participants in COVID-19 Trials.
J Infect Dis. 2020;222:356-361.
PubMed Abstract available

MALKOVSKY M
Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.
J Infect Dis. 2020;222:509-510.
PubMed

DAVERIO M, Amigoni A, Cavicchiolo ME
Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.
J Infect Dis. 2020;222:517-518.
PubMed

June 2020

O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study.
J Infect Dis. 2020 Jun 30. pii: 5865447. doi: 10.1093.
PubMed Abstract available

HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
PubMed Abstract available

LI L, Li X, Guo Z, Wang Z, et al
Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs.
J Infect Dis. 2020;222:203-205.
PubMed Abstract available

RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
J Infect Dis. 2020;222:214-222.
PubMed Abstract available

BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:206-213.
PubMed Abstract available

KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
J Infect Dis. 2020;222:194-197.
PubMed Abstract available

CAI XF, Chen J, Li Hu J, Long QX, et al
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
J Infect Dis. 2020;222:189-193.
PubMed Abstract available

JIANG M, Guo Y, Luo Q, Huang Z, et al
T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
J Infect Dis. 2020;222:198-202.
PubMed Abstract available

ZHANG G, Nie S, Zhang Z, Zhang Z, et al
Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
J Infect Dis. 2020;222:183-188.
PubMed Abstract available

SEPPALA EM, Oikarinen S, Lehtonen JP, Neupane S, et al
Association of Picornavirus Infections With Acute Otitis Media in a Prospective Birth Cohort Study.
J Infect Dis. 2020;222:324-332.
PubMed Abstract available

THIELEN BK, Bye E, Wang X, Maroushek S, et al
Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.
J Infect Dis. 2020;222:288-297.
PubMed Abstract available

UUSITUPA E, Waris M, Heikkinen T
Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;222:298-304.
PubMed Abstract available

KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
PubMed Abstract available

JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
PubMed Abstract available

MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
PubMed Abstract available

ZHANG Y, Qin L, Zhao Y, Zhang P, et al
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
J Infect Dis. 2020;222:34-37.
PubMed Abstract available

ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020;222:38-43.
PubMed Abstract available

NIE X, Fan L, Mu G, Tan Q, et al
Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
J Infect Dis. 2020;222:26-33.
PubMed Abstract available

NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
J Infect Dis. 2020;222:17-25.
PubMed Abstract available

MOORE HC, Lim FJ, Fathima P, Barnes R, et al
Assessing the Burden of Laboratory-Confirmed Respiratory Syncytial Virus Infection in a Population Cohort of Australian Children Through Record Linkage.
J Infect Dis. 2020;222:92-101.
PubMed Abstract available

MIDULLA F, Di Mattia G, Nenna R, Scagnolari C, et al
Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis.
J Infect Dis. 2020;222:102-110.
PubMed Abstract available

JIANG XL, Zhang XL, Zhao XN, Li CB, et al
Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
J Infect Dis. 2020;221:1948-1952.
PubMed Abstract available

PAN Y, Yu X, Du X, Li Q, et al
Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
J Infect Dis. 2020;221:1940-1947.
PubMed Abstract available

ALLEN J
My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
J Infect Dis. 2020;221:1938-1939.
PubMed

URSIN RL, Liu H, Powell HR, Westerbeck J, et al
Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
PubMed Abstract available

SINGH JA
The case for why Africa should host COVID-19 candidate vaccine trials.
J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
PubMed Abstract available

HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort.
J Infect Dis. 2020 Jun 2. pii: 5850322. doi: 10.1093.
PubMed Abstract available

KANG CK, Kim HR, Song KH, Keam B, et al
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
PubMed Abstract available

May 2020

ROBERTS NJ
Further discussion of a likely explanation for decreased peripheral blood anti-influenza CD8+ T cell activity during severe infection.
J Infect Dis. 2020 May 27. pii: 5847826. doi: 10.1093.
PubMed

FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
PubMed Abstract available

COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
PubMed Abstract available

WANG F, Nie J, Wang H, Zhao Q, et al
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
J Infect Dis. 2020;221:1762-1769.
PubMed Abstract available

WANG Y, Liu Y, Liu L, Wang X, et al
Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
J Infect Dis. 2020;221:1770-1774.
PubMed Abstract available

CUI Y, Tian M, Huang D, Wang X, et al
A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
J Infect Dis. 2020;221:1775-1781.
PubMed Abstract available

YU P, Zhu J, Zhang Z, Han Y, et al
A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
J Infect Dis. 2020;221:1757-1761.
PubMed Abstract available

COWLING BJ, Aiello AE
Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
J Infect Dis. 2020;221:1749-1751.
PubMed

ZHANG N, Zhu L, Zhang Y, Zhou C, et al
Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
PubMed Abstract available

BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
What if the Influenza Vaccine Did Not Offer Such Variable Protection?
J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
PubMed Abstract available

TURNER JS, Lei T, Schmitz AJ, Day A, et al
Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.
J Infect Dis. 2020 May 5. pii: 5830762. doi: 10.1093.
PubMed Abstract available

GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
PubMed

April 2020

CIOFFI A
COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
PubMed

WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
PubMed Abstract available

ACKERSON B, An J, Sy LS, Solano Z, et al
Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
PubMed Abstract available

RYU S, Ali ST, Cowling BJ, Lau EHY, et al
Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
PubMed Abstract available

MOHN KG, Brokstad KA, Islam S, Oftung F, et al
Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
J Infect Dis. 2020;221:1528-1537.
PubMed Abstract available

INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
PubMed Abstract available

SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
A high fat diet increases influenza A virus-associated cardiovascular damage.
J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
PubMed Abstract available

March 2020

EYAL N, Lipsitch M, Smith PG
Human challenge studies to accelerate coronavirus vaccine licensure.
J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
PubMed Abstract available

SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
J Infect Dis. 2020;221:1256-1270.
PubMed Abstract available

PIEDRA PA
Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
J Infect Dis. 2020;221:1205-1207.
PubMed

CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
J Infect Dis. 2020;221:1244-1255.
PubMed Abstract available

SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
PubMed Abstract available

DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
Hospital Readmissions following Laboratory-confirmed Influenza Hospitalization.
J Infect Dis. 2020 Mar 17. pii: 5808013. doi: 10.1093.
PubMed Abstract available

FONG MW, Leung NHL, Xiao J, Chu DKW, et al
Presence of influenza virus on touch-surfaces in kindergartens and primary schools.
J Infect Dis. 2020 Mar 16. pii: 5807949. doi: 10.1093.
PubMed Abstract available

ZOU P, Wang C, Zheng S, Guo F, et al
Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study.
J Infect Dis. 2020;221.
PubMed Abstract available

PHILIPPON DAM, Wu P, Cowling BJ, Lau EHY, et al
Avian influenza human infections at the human-animal interface.
J Infect Dis. 2020 Mar 10. pii: 5802683. doi: 10.1093.
PubMed Abstract available

LEES C, Godin J, McElhaney JE, McNeil SA, et al
Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
J Infect Dis. 2020 Mar 9. pii: 5799273. doi: 10.1093.
PubMed

GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
J Infect Dis. 2020;221:882-889.
PubMed Abstract available

February 2020

IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
PubMed Abstract available

SATO M, Takashita E, Katayose M, Nemoto K, et al
Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
PubMed Abstract available

FUENTES S, Hahn M, Chilcote K, Chemaly RF, et al
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
J Infect Dis. 2020;221:636-646.
PubMed Abstract available

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
PubMed Abstract available

January 2020

GUBAREVA LV, Fry AM
Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
J Infect Dis. 2020;221:337-339.
PubMed

MONTO AS
Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
J Infect Dis. 2020;221:340-342.
PubMed

BOONYARATANAKORNKIT J, Vivek M, Xie H, Pergam SA, et al
Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
J Infect Dis. 2020;221:379-388.
PubMed Abstract available

December 2019

DAWOOD FS, Garg S, Fink RV, Russell ML, et al
Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
PubMed Abstract available

SHI N, Huang J, Zhang X, Bao C, et al
Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
PubMed

KISO M, Yamayoshi S, Murakami J, Kawaoka Y, et al
Baloxavir marboxil treatment of nude mice infected with influenza A virus.
J Infect Dis. 2019 Dec 14. pii: 5677533. doi: 10.1093.
PubMed Abstract available

WANG Y, Fan G, Salam A, Horby P, et al
Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
J Infect Dis. 2019 Dec 11. pii: 5673088. doi: 10.1093.
PubMed Abstract available

November 2019

SCHUIT M, Gardner S, Wood S, Bower K, et al
The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols.
J Infect Dis. 2019 Nov 28. pii: 5645407. doi: 10.1093.
PubMed Abstract available

TENG MN, Mejias A, Ramilo O, Peeples ME, et al
Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
PubMed

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
PubMed Abstract available

KEITEL WA, Atmar RL
Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
PubMed

WALKER JL, Zhao H, Dabrera G, Andrews N, et al
Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
PubMed Abstract available

LEE HS, Noh JY, Shin OS, Song JY, et al
Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
J Infect Dis. 2019 Nov 6. pii: 5613981. doi: 10.1093.
PubMed Abstract available

WALKER TA, Waite B, Thompson MG, McArthur C, et al
Risk of Severe Influenza among Adults with Chronic Medical Conditions.
J Infect Dis. 2019 Nov 4. pii: 5611323. doi: 10.1093.
PubMed Abstract available

October 2019

COHEN C, Nunes MC
Vaccinating Mothers to Protect Their Babies Against Influenza.
J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
PubMed

FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
PubMed Abstract available

ATMAR RL, Keitel WA
Searching for Improved Flu Vaccines - The Time Is Now.
J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
PubMed

MARTINEZ L, Cheng W, Wang X, Ling F, et al
A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.
PubMed Abstract available

LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
PubMed

KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
PubMed Abstract available

PARK YH, Chungu K, Lee SB, Woo SJ, et al
Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members.
J Infect Dis. 2019 Oct 3. pii: 5580703. doi: 10.1093.
PubMed Abstract available

September 2019

L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
PubMed Abstract available

GERSHON AS, Chung H, Porter J, Campitelli MA, et al
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
PubMed Abstract available

RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
PubMed

CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
PubMed Abstract available

August 2019

STACEY HD, Miller MS
Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
PubMed

RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
PubMed Abstract available

CHECKMAHOMED L, M'hamdi Z, Carbonneau J, Venable MC, et al
Impact of the baloxavir-resistant polymerase acid (PA) I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains.
J Infect Dis. 2019 Aug 16. pii: 5550847. doi: 10.1093.
PubMed Abstract available

SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
PubMed Abstract available

MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
PubMed Abstract available

July 2019

SHI N, Huang J, Zhang X, Bao C, et al
Interventions in live poultry markets for the control of avian influenza: A systematic review and meta-analysis.
J Infect Dis. 2019 Jul 17. pii: 5533237. doi: 10.1093.
PubMed Abstract available

VENKATESAN S, Myles PR, Bolton KJ, Muthuri SG, et al
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
J Infect Dis. 2019 Jul 17. pii: 5533434. doi: 10.1093.
PubMed Abstract available

UEHARA T, Hayden FG, Kawaguchi K, Omoto S, et al
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
J Infect Dis. 2019 Jul 16. pii: 5532607. doi: 10.1093.
PubMed Abstract available

LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
PubMed Abstract available

CHUA H, Chiu SS, Chan ELY, Feng S, et al
Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
PubMed Abstract available

SHORT KR, Kuiken T, van Riel D
The role of endothelial cells in the pathogenesis of influenza in humans.
J Infect Dis. 2019 Jul 8. pii: 5529824. doi: 10.1093.
PubMed

JIA W, Wen X, Xie S, Dai Y, et al
A Novel Antigenic Drift of Avian Influenza A(H7N9) Virus in Poultry, China, 2018.
J Infect Dis. 2019 Jul 8. pii: 5529482. doi: 10.1093.
PubMed

NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
PubMed Abstract available

June 2019

LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
PubMed Abstract available

GERN JE, Lee WM, Swenson CA, Nakagome K, et al
Development of a Rhinovirus Inoculum Using a Reverse Genetics Approach.
J Infect Dis. 2019;220:187-194.
PubMed Abstract available

PROUD D
Reverse Genetics and Rhinovirus-A New Approach to an Old Problem?
J Infect Dis. 2019;220:181-183.
PubMed

POLACK FP, Stein RT, Custovic A
The Syndrome We Agreed to Call Bronchiolitis.
J Infect Dis. 2019;220:184-186.
PubMed Abstract available

ZHONG W, Levine MZ
Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
PubMed Abstract available

May 2019

GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
PubMed Abstract available

REDLBERGER-FRITZ M, Vietzen H, Puchhammer-Stockl E
Association of severe influenza virus infections with CD226 (DNAM-1) variants.
J Infect Dis. 2019 May 21. pii: 5494791. doi: 10.1093.
PubMed Abstract available

CILLONIZ C, Dominedo C, Magdaleno D, Ferrer M, et al
Pure viral sepsis secondary to Community-Acquired Pneumonia in adults: risk and prognostic factors.
J Infect Dis. 2019 May 21. pii: 5494607. doi: 10.1093.
PubMed Abstract available

MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
Remaining effect of influenza vaccines received in prior seasons.
J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
PubMed Abstract available

MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
PubMed Abstract available

MANSBACH JM, Hasegawa K, Piedra PA, Avadhanula V, et al
Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
J Infect Dis. 2019;219:1804-1808.
PubMed Abstract available

BUDD AP, Beacham L, Smith CB, Garten RJ, et al
Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness.
J Infect Dis. 2019 May 3. pii: 5485579. doi: 10.1093.
PubMed Abstract available

AMOAH S, Mishina M, Praphasiri P, Cao W, et al
Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
PubMed Abstract available

April 2019

AMBIGAPATHY G, Schmit T, Mathur RK, Nookala S, et al
Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.
J Infect Dis. 2019 Apr 23. pii: 5476446. doi: 10.1093.
PubMed Abstract available

CHAN LLY, Hui KPY, Kuok DIT, Bui CHT, et al
Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract.
J Infect Dis. 2019 Apr 18. pii: 5475154. doi: 10.1093.
PubMed Abstract available

GARCIA-MAURINO C, Moore-Clingenpeel M, Thomas J, Mertz S, et al
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.
J Infect Dis. 2019;219:1207-1215.
PubMed Abstract available

YU J, Peterson DR, Baran AM, Bhattacharya S, et al
Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection.
J Infect Dis. 2019;219:1151-1161.
PubMed Abstract available

March 2019

KAMAU E, Onyango CO, Otieno GP, Kiyuka PK, et al
An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households.
J Infect Dis. 2019;219:1049-1057.
PubMed Abstract available

ROOT JJ
What Are the Transmission Mechanisms of Influenza A Viruses in Wild Mammals?
J Infect Dis. 2019 Mar 6. pii: 5369377. doi: 10.1093.
PubMed

SOILEMETZIDOU ES, De Bruin E, Franz M, Aschenborn OHK, et al
Diet May Drive Influenza A Virus Exposure in African Mammals.
J Infect Dis. 2019 Mar 6. pii: 5369376. doi: 10.1093.
PubMed Abstract available

February 2019

THORNTON AC, Parry-Ford F, Tessier E, Oppilamany N, et al
Human exposures to H5N6 Avian influenza, England, 2018.
J Infect Dis. 2019 Feb 21. pii: 5351024. doi: 10.1093.
PubMed Abstract available

FU Y, Durrwald R, Meng F, Tong J, et al
Infection Studies in Pigs and Porcine Airway Epithelial Cells Reveal an Evolution of A(H1N1)pdm09 Influenza A Viruses Toward Lower Virulence.
J Infect Dis. 2019 Feb 18. pii: 5334094. doi: 10.1093.
PubMed Abstract available

VAN ERP EA, Feyaerts D, Duijst M, Mulder HL, et al
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.
J Infect Dis. 2019;219:723-733.
PubMed Abstract available

ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
PubMed Abstract available

LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
PubMed Abstract available

January 2019

PAULES CI, Fauci AS
Influenza Vaccines: Good, But We Can Do Better.
J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
PubMed

SAAD-ROY CM, McDermott AB, Grenfell BT
Dynamic perspectives on the search for a universal influenza vaccine.
J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
PubMed Abstract available

CRANK MC, Mascola JR, Graham BS
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
PubMed

RUDRARAJU R, Mordant F, Subbarao K
How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
PubMed

ROSS TM
Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
PubMed Abstract available

SANT AJ
The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
PubMed Abstract available

CROWE JE JR
Antibody Determinants of Influenza Immunity.
J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
PubMed Abstract available

NEUMANN G, Kawaoka Y
Can We Predict The Next Influenza Pandemics?
J Infect Dis. 2019 Jan 31. pii: 5304929. doi: 10.1093.
PubMed Abstract available

SAELENS X
The Role of M2e in the Development of Universal Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
PubMed Abstract available

EICHELBERGER MC, Monto AS
Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
PubMed Abstract available

KRAMMER F, Palese P
Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
PubMed Abstract available

MORENS DM, Taubenberger JK
Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
PubMed

ORTIZ JR, Neuzil KM
Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
PubMed Abstract available

KANEKIYO M, Ellis D, King NP
New Vaccine Design and Delivery Technologies.
J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
PubMed Abstract available

ANDERSON LJ, Peret TC, Piedra PA
RSV Strains and Disease Severity.
J Infect Dis. 2019;219:514-516.
PubMed

MIDULLA F, Nenna R, Scagnolari C, Petrarca L, et al
How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.
J Infect Dis. 2019;219:526-534.
PubMed Abstract available

PRASAD N, Huang QS, Wood T, Aminisani N, et al
Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age.
J Infect Dis. 2019 Jan 23. pii: 5299596. doi: 10.1093.
PubMed Abstract available

CABALLERO MT, Bianchi AM, Nuno A, Ferretti AJP, et al
Mortality Associated With Acute Respiratory Infections Among Children at Home.
J Infect Dis. 2019;219:358-364.
PubMed Abstract available

FURUSE Y, Tamaki R, Okamoto M, Saito-Obata M, et al
Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.
J Infect Dis. 2019;219:197-205.
PubMed Abstract available

MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
J Infect Dis. 2019;219:59-67.
PubMed Abstract available

December 2018

HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
PubMed Abstract available

LAUZON-JOSET JF, Scott NM, Mincham KT, Stumbles PA, et al
Pregnancy induces a steady-state shift in alveolar macrophage M1/M2 phenotype that is associated with a heightened severity of Influenza infection: mechanistic insight using mouse models.
J Infect Dis. 2018 Dec 21. pii: 5257349. doi: 10.1093.
PubMed Abstract available

HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
PubMed Abstract available

FLANNERY B, Fry AM
Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
PubMed

IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
PubMed Abstract available

NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
PubMed Abstract available

KEITEL WA, Atmar RL
Influenza Vaccines after Seven Decades: Still on the Learning Curve.
J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
PubMed

FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
PubMed Abstract available

COHEN C, Tshangela A, Valley-Omar Z, Iyengar P, et al
Household transmission of seasonal influenza from HIV-infected and -uninfected individuals in South Africa, 2013-2014.
J Infect Dis. 2018 Dec 12. pii: 5240968. doi: 10.1093.
PubMed Abstract available

ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
PubMed

JENNIFER R, Green WD, Alwarawrah Y, Nichols AG, et al
Obesity-induced changes in T cell metabolism are associated with impaired memory T cell response to influenza and are not reversed with weight loss.
J Infect Dis. 2018 Dec 9. pii: 5236852. doi: 10.1093.
PubMed Abstract available

November 2018

SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
Diminished B-cell response after repeat influenza vaccination.
J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
PubMed Abstract available

LEE N, Ison MG
Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza.
J Infect Dis. 2018 Nov 14. pii: 5183287. doi: 10.1093.
PubMed

FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
PubMed Abstract available

POIROT E, Levine MZ, Russell K, Stewart RJ, et al
Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.
J Infect Dis. 2018 Nov 5. pii: 5161222. doi: 10.1093.
PubMed Abstract available

JAIN S, Murray EL
The Cat's Meow: Using Novel Serological Approaches to Identify Cat-to-Human Influenza A(H7N2) Transmission.
J Infect Dis. 2018 Nov 3. pii: 5159540. doi: 10.1093.
PubMed

September 2018

SCHELLER N, Herold S, Kellner R, Bertrams W, et al
Pro-viral miRNAs detected in BALF extracellular vesicles of patients with influenza virus-induced ARDS.
J Infect Dis. 2018 Sep 15. pii: 5098403. doi: 10.1093.
PubMed Abstract available

L'HUILLIER AG, Ferreira VH, Hirzel C, Cordero E, et al
Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients.
J Infect Dis. 2018 Sep 5. pii: 5091250. doi: 10.1093.
PubMed Abstract available

MORI I
1918 H1N1 Influenza Virus Infection-Induced Proinflammatory Cytokines in the Olfactory Bulb Could Trigger Lethargic Disease.
J Infect Dis. 2018 Sep 4. pii: 5090304. doi: 10.1093.
PubMed

August 2018

MAIER HE, Lopez R, Sanchez N, Ng S, et al
Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
J Infect Dis. 2018 Aug 2. pii: 5051913. doi: 10.1093.
PubMed Abstract available

LOY H, Kuok DIT, Hui KPY, Choi MHL, et al
Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury.
J Infect Dis. 2018 Aug 2. pii: 5064213. doi: 10.1093.
PubMed Abstract available

SCHULTZ-CHERRY S
Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.
J Infect Dis. 2018 Aug 2. pii: 5051914. doi: 10.1093.
PubMed

July 2018

YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
PubMed Abstract available

TREANOR J
Influenza Challenge and the Challenge of Drug Development.
J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
PubMed

HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
PubMed Abstract available

COWLING BJ, Sullivan SG
The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
PubMed

ZHOU X, Wang Y, Liu H, Guo F, et al
Effectiveness of market-level biosecurity at reducing exposure of poultry and humans to avian influenza: a systematic review and meta-analysis.
J Infect Dis. 2018 Jul 7. pii: 5050226. doi: 10.1093.
PubMed Abstract available

PETRIE JG, Lauring AS
Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
J Infect Dis. 2018 Jul 5. pii: 5049176. doi: 10.1093.
PubMed

NING T, Nie J, Huang W, Li C, et al
Antigenic Drift of H7N9 Viral Hemagglutinin.
J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
PubMed Abstract available

June 2018

LIU F, Tzeng WP, Horner L, Kamal RP, et al
Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
PubMed Abstract available

KORMUTH KA, Lin K, Prussin AJ 2nd, Vejerano EP, et al
Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity.
J Infect Dis. 2018 Jun 7. pii: 5025997. doi: 10.1093.
PubMed Abstract available

HOULIHAN C, Frampton D, Ferns RB, Raffle J, et al
The use of whole genome sequencing in the investigation of a nosocomial influenza virus outbreak.
J Infect Dis. 2018 Jun 5. pii: 5033093. doi: 10.1093.
PubMed Abstract available

May 2018

VANDERVEN HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, et al
Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.
J Infect Dis. 2018 May 31. pii: 5026129. doi: 10.1093.
PubMed Abstract available

GUAN W, Wu NC, Lee HHY, Li Y, et al
Clinical Correlations of Transcriptional Profile in Patients Infected with Avian Influenza H7N9 Virus.
J Infect Dis. 2018 May 28. pii: 5017262. doi: 10.1093.
PubMed Abstract available

VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
PubMed Abstract available

RICHARDS KA, Treanor JJ, Nayak JL, Sant AJ, et al
Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B CD4 T Cell Repertoire.
J Infect Dis. 2018 May 12. pii: 4995466. doi: 10.1093.
PubMed Abstract available

CHAN KF, Carolan LA, Korenkov D, Druce J, et al
Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
J Infect Dis. 2018 May 8. pii: 4994087. doi: 10.1093.
PubMed Abstract available

April 2018

CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
PubMed Abstract available

DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
PubMed Abstract available

BORGOGNA TR, Hisey B, Heitmann E, Obar JJ, et al
Secondary Bacterial Pneumonia by Staphylococcus aureus following Influenza A Infection Is SaeR/S Dependent.
J Infect Dis. 2018 Apr 13. pii: 4970008. doi: 10.1093.
PubMed Abstract available

VAN DE SANDT CE, Sagong KA, Pronk MR, Bestebroer TM, et al
H1N1pdm09 Influenza Virus and its Descendants Lack Extra-Epitopic Amino Acid Residues Associated with Reduced Recognition by M158-66-specific CD8+ T-cells.
J Infect Dis. 2018 Apr 12. pii: 4969428. doi: 10.1093.
PubMed Abstract available

WANG Y, Guo Q, Yan Z, Zhou D, et al
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.
J Infect Dis. 2018 Apr 10. pii: 4965883. doi: 10.1093.
PubMed Abstract available

March 2018

LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
PubMed Abstract available

POLACK FP
Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
PubMed

BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
PubMed Abstract available

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
PubMed Abstract available

February 2018

ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
PubMed Abstract available

YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
PubMed Abstract available

XIANG D, Shen X, Pu Z, Irwin DM, et al
Convergent Evolution of Human-Isolated H7N9 Avian Influenza A Viruses.
J Infect Dis. 2018 Feb 9. pii: 4846861. doi: 10.1093.
PubMed Abstract available

BERAN J, Lickliter JD, Schwarz TF, Johnson C, et al
Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials.
J Infect Dis. 2018 Feb 1. pii: 4833521. doi: 10.1093.
PubMed Abstract available

January 2018

MAEMURA T, Fukuyama S, Sugita Y, Lopes TJS, et al
Lung-derived exosomal miR-483-3p regulates the innate immune response to influenza virus infection.
J Infect Dis. 2018 Jan 24. pii: 4823229. doi: 10.1093.
PubMed Abstract available

CHENG AC, Subbarao K
Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
PubMed

FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
PubMed Abstract available

ZHU L, Liu L, Zhang Y, Pu L, et al
High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.
J Infect Dis. 2018;217:428-437.
PubMed Abstract available

STORCH GA
Respiratory Viruses in Babies: Important Insights From Down Under.
J Infect Dis. 2018;217:350-352.
PubMed

CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
PubMed Abstract available

ROLFES MA, Gross FL, Flannery B, Meyers AFA, et al
Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.
J Infect Dis. 2018 Jan 12. pii: 4803439. doi: 10.1093.
PubMed Abstract available

DE WIT E, Siegers J, Cronin JM, Weatherman S, et al
1918 H1N1 influenza virus replicates and induces pro-inflammatory cytokine responses in extra-respiratory tissues of ferrets.
J Infect Dis. 2018 Jan 10. pii: 4796831. doi: 10.1093.
PubMed Abstract available

LAURIE KL, Horman W, Carolan LA, Chan KF, et al
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
J Infect Dis. 2018 Jan 6. pii: 4792826. doi: 10.1093.
PubMed Abstract available

GOLDSTEIN E, Nguyen HH, Liu P, Viboud C, et al
On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus.
J Infect Dis. 2018;217:238-244.
PubMed Abstract available

December 2017

RAMILO O, Rodriguez-Fernandez R, Mejias A
One Step Forward in the Road Toward a Universal Influenza Vaccine.
J Infect Dis. 2017;217:1-2.
PubMed

DE VRIES RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, et al
Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
J Infect Dis. 2017;217:3-11.
PubMed Abstract available

CAPELLA C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, et al
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
J Infect Dis. 2017;216:1398-1406.
PubMed Abstract available

MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
PubMed

YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
PubMed Abstract available

OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
PubMed Abstract available

LIU WC, Lin CS, Yeh CC, Wu HY, et al
Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
PubMed Abstract available

WAGHMARE A, Xie H, Kimball L, Yi J, et al
Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
J Infect Dis. 2017;216:1235-1244.
PubMed Abstract available

November 2017

MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
PubMed Abstract available

LU X, Schneider E, Jain S, Bramley AM, et al
Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.
J Infect Dis. 2017;216:1104-1111.
PubMed Abstract available

KISO M, Lopes TJS, Yamayoshi S, Ito M, et al
Combination Therapy with Neuraminidase and Polymerase Inhibitors in Nude Mice Infected with Influenza Virus.
J Infect Dis. 2017 Nov 25. pii: 4662841. doi: 10.1093.
PubMed Abstract available

MARIANI TJ, Qiu X, Chu C, Wang L, et al
Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.
J Infect Dis. 2017;216:1027-1037.
PubMed Abstract available

SEON SH, Choi JA, Yang E, Pyo S, et al
Intranasal Immunization with an Attenuated Pep27 Mutant Provides Protection from Influenza Virus and Secondary Pneumococcal Infections.
J Infect Dis. 2017 Nov 14. doi: 10.1093.
PubMed Abstract available

WONG SS, Oshansky CM, Guo XJ, Ralston J, et al
Severe influenza is characterized by prolonged immune activation: results from the SHIVERS cohort study.
J Infect Dis. 2017 Nov 3. doi: 10.1093.
PubMed Abstract available

VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
J Infect Dis. 2017 Nov 2. doi: 10.1093.
PubMed Abstract available

October 2017

SKOWRONSKI DM, Chambers C, De Serres G
Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
J Infect Dis. 2017 Oct 13. doi: 10.1093.
PubMed

SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
J Infect Dis. 2017 Oct 4. doi: 10.1093.
PubMed Abstract available

September 2017

BELONGIA E
Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
J Infect Dis. 2017 Sep 27. doi: 10.1093.
PubMed

OXMAN MN, Harbecke R, Koelle DM
Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
J Infect Dis. 2017 Sep 26. doi: 10.1093.
PubMed

SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
J Infect Dis. 2017 Sep 26. doi: 10.1093.
PubMed Abstract available

FALLOON J, Yu J, Esser MT, Villafana T, et al
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
J Infect Dis. 2017 Sep 23. doi: 10.1093.
PubMed Abstract available

LANGLEY JM
Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
J Infect Dis. 2017 Sep 23. doi: 10.1093.
PubMed

WIDDOWSON MA, Bresee JS, Jernigan DB
The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
J Infect Dis. 2017;216.
PubMed Abstract available

LIU B, Havers FP, Zhou L, Zhong H, et al
Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015.
J Infect Dis. 2017;216.
PubMed Abstract available

LIU F, Veguilla V, Gross FL, Gillis E, et al
Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
J Infect Dis. 2017;216.
PubMed Abstract available

HAVERS FP, Campbell AP, Uyeki TM, Fry AM, et al
Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease.
J Infect Dis. 2017;216.
PubMed Abstract available

CHAKRABORTY A, Rahman M, Hossain MJ, Khan SU, et al
Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.
J Infect Dis. 2017;216.
PubMed Abstract available

VENTER M, Treurnicht FK, Buys A, Tempia S, et al
Risk of Human Infections With Highly Pathogenic H5N2 and Low Pathogenic H7N1 Avian Influenza Strains During Outbreaks in Ostriches in South Africa.
J Infect Dis. 2017;216.
PubMed Abstract available

CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
J Infect Dis. 2017;216.
PubMed Abstract available

LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
J Infect Dis. 2017;216.
PubMed Abstract available

GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
J Infect Dis. 2017;216.
PubMed Abstract available

PULIT-PENALOZA JA, Simpson N, Yang H, Creager HM, et al
Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.
J Infect Dis. 2017;216.
PubMed Abstract available

JONES EN, Amoah S, Cao W, Sambhara S, et al
An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
J Infect Dis. 2017;216.
PubMed Abstract available

BELSER JA, Creager HM, Zeng H, Maines TR, et al
Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.
J Infect Dis. 2017;216.
PubMed Abstract available

SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
J Infect Dis. 2017;216:697-702.
PubMed Abstract available

SCHLABERG R, Ampofo K, Tardif KD, Stockmann C, et al
Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.
J Infect Dis. 2017;216:688-696.
PubMed Abstract available

DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
J Infect Dis. 2017 Sep 9. doi: 10.1093.
PubMed Abstract available

KISO M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, et al
Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
J Infect Dis. 2017;216:582-593.
PubMed Abstract available

August 2017

NEUZIL KM, Chen WH
Influenza Vaccines for Older Persons: Progress and Pitfalls.
J Infect Dis. 2017;216:397-398.
PubMed

ANDREW MK, Shinde V, Ye L, Hatchette T, et al
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
J Infect Dis. 2017;216:405-414.
PubMed Abstract available

VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
J Infect Dis. 2017;216:415-424.
PubMed Abstract available

MCELHANEY JE, McNeil SA
Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
J Infect Dis. 2017;216:399-401.
PubMed

MIDGLEY CM, Haynes AK, Baumgardner JL, Chommanard C, et al
Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.
J Infect Dis. 2017;216:345-355.
PubMed Abstract available

July 2017

YOON SW, Wong SS, Zhu H, Chen R, et al
Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus.
J Infect Dis. 2017 Jul 18. doi: 10.1093.
PubMed Abstract available

MOE N, Stenseng IH, Krokstad S, Christensen A, et al
The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
J Infect Dis. 2017;216:110-116.
PubMed Abstract available

June 2017

PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al
An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
J Infect Dis. 2017 Jun 17. doi: 10.1093.
PubMed Abstract available

SHORT KR, Veeris R, Leijten LM, van den Brand JM, et al
Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza.
J Infect Dis. 2017 Jun 16. doi: 10.1093.
PubMed Abstract available

MONTO AS, Malosh RE, Petrie JG, Martin ET, et al
The Doctrine of Original Antigenic Sin: Separating Good From Evil.
J Infect Dis. 2017;215:1782-1788.
PubMed Abstract available

CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
J Infect Dis. 2017 Jun 13. doi: 10.1093.
PubMed

DATTA S, Walsh EE, Peterson DR, Falsey AR, et al
Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?
J Infect Dis. 2017;215:1706-1710.
PubMed Abstract available

May 2017

RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
J Infect Dis. 2017 May 20. doi: 10.1093.
PubMed Abstract available

LEE N, Cao B, Ke C, Lu H, et al
IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza.
J Infect Dis. 2017 May 16. doi: 10.1093.
PubMed Abstract available

HIROSE R, Nakaya T, Naito Y, Daidoji T, et al
Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices.
J Infect Dis. 2017 May 11. doi: 10.1093.
PubMed Abstract available

AGUAYO-HIRALDO PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, et al
Characterizing the cellular immune response to Parainfluenza virus 3.
J Infect Dis. 2017 May 2. doi: 10.1093.
PubMed Abstract available

WAGHMARE A, Englund JA, Boeckh M
Parainfluenza Virus 3-specific T Cells: Opportunity for Intervention?
J Infect Dis. 2017 May 2. doi: 10.1093.
PubMed

SCHLABERG R, Queen K, Simmon K, Tardif K, et al
Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology.
J Infect Dis. 2017;215:1407-1415.
PubMed Abstract available

April 2017

THWAITES RS, Ito K, Chingono JMS, Coates M, et al
Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.
J Infect Dis. 2017;215:1240-1244.
PubMed Abstract available

HUANG X, Mengersen K, Milinovich G, Hu W, et al
Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
J Infect Dis. 2017 Apr 12. doi: 10.1093.
PubMed Abstract available

March 2017

MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
J Infect Dis. 2017 Mar 27. doi: 10.1093.
PubMed Abstract available

PETRIE JG, Monto AS
Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
J Infect Dis. 2017;215:841-843.
PubMed

MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
J Infect Dis. 2017;215:847-855.
PubMed Abstract available

SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
J Infect Dis. 2017 Mar 2. doi: 10.1093.
PubMed Abstract available

MONTO AS
Moving Toward Improved Influenza Vaccines.
J Infect Dis. 2017 Mar 2. doi: 10.1093.
PubMed

CASERTA MT, Qiu X, Tesini B, Wang L, et al
Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.
J Infect Dis. 2017;215:750-756.
PubMed Abstract available

February 2017

LIU L, Nachbagauer R, Zhu L, Huang Y, et al
Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
J Infect Dis. 2017;215:518-528.
PubMed Abstract available

SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
J Infect Dis. 2017 Feb 9. doi: 10.1093.
PubMed

BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
J Infect Dis. 2017 Feb 9. doi: 10.1093.
PubMed

PETRIE JG, Monto AS
Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
J Infect Dis. 2017 Feb 7. doi: 10.1093.
PubMed

MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
J Infect Dis. 2017 Feb 7. doi: 10.1093.
PubMed

January 2017

ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
Consecutive Influenza Infections in Both Adults and Children.
J Infect Dis. 2017 Jan 18. doi: 10.1093.
PubMed

HEIKKINEN T, Ojala E, Waris M
Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
J Infect Dis. 2017;215:17-23.
PubMed Abstract available

December 2016

EWING A, Lee EC, Viboud C, Bansal S, et al
Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
PubMed Abstract available

HADLER JL
Christmas-New Year influenza lull: not too late for vaccination.
J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
PubMed

JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
PubMed Abstract available

TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
PubMed Abstract available

PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
J Infect Dis. 2016;214:1947-1951.
PubMed Abstract available

SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
J Infect Dis. 2016;214:1929-1936.
PubMed Abstract available

FEDSON DS
Statins, Influenza Vaccination and Influenza.
J Infect Dis. 2016.
PubMed

FEDSON DS
Statins, Influenza Vaccination and Influenza.
J Infect Dis. 2016 Dec 7. doi: 10.1093.
PubMed

October 2016

LIU WJ, Tan S, Zhao M, Quan C, et al
Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
J Infect Dis. 2016.
PubMed Abstract available

MORI I
Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
J Infect Dis. 2016.
PubMed

Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
J Infect Dis. 2016.
PubMed

September 2016

LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
J Infect Dis. 2016.
PubMed Abstract available

LE GARS M, Kay AW, Bayless NL, Aziz N, et al
Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
J Infect Dis. 2016.
PubMed Abstract available

YU KO, Randolph AG, Agan AA, Yip WK, et al
Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
J Infect Dis. 2016.
PubMed Abstract available

MADAN A, Segall N, Ferguson M, Frenette L, et al
Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
J Infect Dis. 2016.
PubMed Abstract available

July 2016

HOFT DF, Lottenbach K, Goll JB, Hill H, et al
Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
J Infect Dis. 2016.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: